SAN FRANCISCO, August 06, 2025--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in ECLIPSE 3. All three trials in the Company’s registrational ...

All three trials in the Company’s registrational ECLIPSE program for chronic hepatitis delta (CHD) have now been initiated.

Apache Struts is one of the most popular web development frameworks in the history of the Java language, and the Eclipse IDE remains one of the most popular Java IDEs on the market. As such, it only ...

ECLIPSE is a registrational program to evaluate the safety and efficacy of tobevibart in combination with elebsiran in patients with chronic hepatitis delta (CHD).

Updated JDK 25: The new features in Java 25 news Aug 11, 2025 12 mins Java Programming Languages Software Development ...